Phase 1 Metabolic Diseases Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1

FES Cycling With BFR in the Spinal Cord Injury Population

Spinal Cord InjuryMetabolic Diseases, Type 2 Diabetes, Cardiovascular DiseaseCardio Vascular Disease

Dr. B. Catharine. Craven6 enrolled1 locationNCT07588503

Completed

Phase 1

A Phase 1, randomised, double-blind, placebo-controlled, parallel group study to investigate safety, tolerability and pharmacokinetics following multiple dose administration of KAI-7535 in participants with obesity and overweight

ObesityOverweightMetabolic Diseases

Kailera Therapeutics, Inc. 890 Winter Street, Suite 220 Waltham MA 0245, United States46 enrolled2 locationsACTRN12625000782437